> Details

Shokrzadeh, Ayla; Maltret, Alice; Morel, Nathalie; Costedoat-Chalumeau, Nathalie; Driessen, Marine; Raisky, Olivier; Ville, Yves; Bonnet, Damien; Stirnemann, Julien

Longitudinal Analysis of Fetal Ventricular Rate for Risk Stratification in Immune Congenital Heart Block

Reference
management

Bookmarks

Remove from
bookmarks

Share this on Whatsapp

Close

Bookmarks



You can manage bookmarks using lists, please log in to your user account for this.
  • Media type: E-Article
  • Title: Longitudinal Analysis of Fetal Ventricular Rate for Risk Stratification in Immune Congenital Heart Block
  • Contributor: Shokrzadeh, Ayla; Maltret, Alice; Morel, Nathalie; Costedoat-Chalumeau, Nathalie; Driessen, Marine; Raisky, Olivier; Ville, Yves; Bonnet, Damien; Stirnemann, Julien
  • imprint: S. Karger AG, 2021
  • Published in: Fetal Diagnosis and Therapy
  • Language: English
  • DOI: 10.1159/000507811
  • ISSN: 1015-3837; 1421-9964
  • Keywords: Obstetrics and Gynecology ; Radiology, Nuclear Medicine and imaging ; Embryology ; General Medicine ; Pediatrics, Perinatology and Child Health
  • Origination:
  • Footnote:
  • Description: <jats:p>&lt;b&gt;&lt;i&gt;Objectives:&lt;/i&gt;&lt;/b&gt; To assess the perinatal risks of immune complete congenital heart block (iCCHB) based on the longitudinal analysis of fetal heart rate. &lt;b&gt;&lt;i&gt;Methods:&lt;/i&gt;&lt;/b&gt; Retrospective analysis of a cohort of grade III congenital heart block diagnosed in utero, in the absence of associated cardiac defect, with positive maternal serum antibodies. Longitudinal measurements of the fetal heart rate were used to estimate the average slope of ventricular rate as a function of gestational age. We then defined the following prognostic stratification based on longitudinal follow-up observations: the high-rate (HR) group included cases for which all prenatal ventricular rate measurements were above the age-specific mean of our population of iCCHB and the low-rate (LR) group included those with at least one observation below the mean during follow-up. The 2 groups were compared to analyze the potential relationship between prenatal ventricular rate and adverse neonatal outcome defined by in utero or perinatal death, neonatal heart rate &amp;#x3c;50 bpm, or hemodynamic failure requiring emergency pacing. &lt;b&gt;&lt;i&gt;Results:&lt;/i&gt;&lt;/b&gt; Forty-four cases were studied. Overall, the average heart rate significantly decreased during gestation from 65 bpm at 20 weeks to 55 bpm at 38 weeks. The HR and LR groups included 18 (41%) and 26 (59%) cases, respectively. Adverse perinatal outcome occurred in 1/18 (6%) and 22/26 (85%) cases in the HR and LR groups, respectively (&lt;i&gt;p&lt;/i&gt; &amp;#x3c; 0.001). In the HR group, 33% of cases remained nonpaced at &amp;#x3e;6 months. The positive predictive values and negative predictive values for adverse perinatal outcome in the LR group were 85% (22/26) and 94% (17/18), respectively (100 and 80% &amp;#x3c;30 weeks and 88 and 78% at ≥30 weeks). &lt;b&gt;&lt;i&gt;Conclusions:&lt;/i&gt;&lt;/b&gt; The prognostic classification we developed based on longitudinal heart rate assessment may be used in the late 2nd or early 3rd trimester to identify iCCHB cases at high risk of adverse perinatal outcome. This prognostic stratification should help refine counseling and perinatal management earlier in pregnancy instead of waiting for late gestation or predelivery assessment. </jats:p>